» Articles » PMID: 27979394

Editorial Policies for Sex and Gender Analysis

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2016 Dec 17
PMID 27979394
Citations 47
Authors
Affiliations
Soon will be listed here.
Citing Articles

Inclusive oncological trials and targeted treatments cannot ignore sex and gender.

Heinrich K, Oertelt-Prigione S BMJ Oncol. 2025; 2(1):e000051.

PMID: 39886518 PMC: 11203085. DOI: 10.1136/bmjonc-2023-000051.


Integrating gender analysis into research: reflections from the Gender-Net Plus workshop.

Cederroth C, Earp B, Gomez Prada H, Jarach C, Lir S, Norris C EClinicalMedicine. 2024; 74:102728.

PMID: 39105192 PMC: 11299571. DOI: 10.1016/j.eclinm.2024.102728.


Participant characteristics and exclusion from phase 3/4 industry funded trials of chronic medical conditions: meta-analysis of individual participant level data.

Lees J, Crowther J, Hanlon P, Butterly E, Wild S, Mair F BMJ Med. 2024; 3(1):e000732.

PMID: 38737200 PMC: 11085787. DOI: 10.1136/bmjmed-2023-000732.


Short term effects of contralateral tendon vibration on motor unit discharge rate variability and force steadiness in people with Parkinson's disease.

Kim C, Wile D, Kraeutner S, Larocque K, Jakobi J Front Aging Neurosci. 2024; 16:1301012.

PMID: 38529054 PMC: 10962053. DOI: 10.3389/fnagi.2024.1301012.


Outcome differences by sex in oncology clinical trials.

Kammula A, Schaffer A, Rajagopal P, Kurzrock R, Ruppin E Nat Commun. 2024; 15(1):2608.

PMID: 38521835 PMC: 10960820. DOI: 10.1038/s41467-024-46945-x.